In one paragraphArticle in Alimentary pharmacology & therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
11 authors at 4 institutions in 2 countries.
Edward YangDivision of Gastroenterology, Department of Medicine, UCSD Inflammatory Bowel Disease Center, La Jolla, CA, USA.ORCID 0000-0002-5905-5554 Nicola PanaccioneFaculty of Health Science, Western University, London, ON, Canada.
Natalie WhitmireDivision of Gastroenterology, Department of Medicine, UCSD Inflammatory Bowel Disease Center, La Jolla, CA, USA.
Parambir S DulaiDivision of Gastroenterology, Department of Medicine, UCSD Inflammatory Bowel Disease Center, La Jolla, CA, USA.ORCID 0000-0002-9514-2321 Niels Vande CasteeleDivision of Gastroenterology, Department of Medicine, UCSD Inflammatory Bowel Disease Center, La Jolla, CA, USA.ORCID 0000-0002-2380-2124 Siddharth SinghDivision of Gastroenterology, Department of Medicine, UCSD Inflammatory Bowel Disease Center, La Jolla, CA, USA.ORCID 0000-0002-2640-7269 Brigid S BolandDivision of Gastroenterology, Department of Medicine, UCSD Inflammatory Bowel Disease Center, La Jolla, CA, USA.
Angelina CollinsDivision of Gastroenterology, Department of Medicine, UCSD Inflammatory Bowel Disease Center, La Jolla, CA, USA.
William J SandbornDivision of Gastroenterology, Department of Medicine, UCSD Inflammatory Bowel Disease Center, La Jolla, CA, USA.ORCID 0000-0002-3314-7960 Remo PanaccioneDivision of Gastroenterology, Department of Medicine, University of Calgary Inflammatory Bowel Disease Center, Calgary, AB, Canada.
Robert BattatDivision of Gastroenterology, Department of Medicine, UCSD Inflammatory Bowel Disease Center, La Jolla, CA, USA.ORCID 0000-0002-7421-9764 University of California San Diego · USCornell University · USUniversity of Calgary · CAWestern University · CA
Funding
Comparative Risks and Benefits of Pharmacological Therapies for Older Patients with Inflammatory Bowel DiseasesK23DK117058 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SINGH, SIDDHARTH · 2018 to 2022
$971kNIDDK NIH HHS K23 DK117058
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Biological ProductsCrohn DiseaseInflammatory Bowel DiseasesHumansBiological Products
Identifiers
PMID32656846
OpenAlexW3043174949
What OpenQuestion holds
Textmetadata
Read underepoch 390